- In March 2025, Alcon, the global leader in eye care pharmaceuticals, announced an agreement to acquire Lensar, a pioneer in cataract laser surgery. This acquisition is set to enhance Alcon’s femtosecond laser-assisted cataract surgery (FLACS) portfolio, integrating Lensar’s innovative ALLY system, which the company has previously described as a “revolutionary” advancement in the field
- In June 2024, Lumenis introduced Folix, a U.S. FDA-cleared fractional laser designed for hair loss treatment. This innovative laser stimulates hair follicles to promote regrowth while minimizing tissue damage, offering a non-invasive solution for both male and female pattern hair loss
- In February 2024, Biolase Inc. launched the Waterlase iPlus Premier Edition, an all-tissue laser system for dental procedures. This system features modular software with customizable procedure packages, enhanced user experience, and Wi-Fi connectivity, aiming to accelerate its adoption in dentistry
- In January 2024, DEKA, an Italian subsidiary of the El.En. Group, launched four new laser platforms under the "PRO" line. These platforms aim to transform traditional dermatological laser technology paradigms, cosmetic medicine, and dermatologic surgery
- In March 2021, Lumenis and Baring Private Equity Asia announced today that they have reached a definitive agreement to sell the Lumenis Surgical Business to Boston Scientific for USD 1.07 billion, subject to closing adjustments. In Urology and ENT, the Surgical Business comprises laser and fibre technologies for less invasive surgical treatments
